IBDEI1M1 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,298,0)
 ;;=OTHER^4^31
 ;;^UTILITY(U,$J,358.4,299,0)
 ;;=PROLONGED CLINICAL STAFF SERVICES^5^31
 ;;^UTILITY(U,$J,358.4,300,0)
 ;;=LAB TESTS^3^31
 ;;^UTILITY(U,$J,358.4,301,0)
 ;;=NEW PATIENT^3^32
 ;;^UTILITY(U,$J,358.4,302,0)
 ;;=ESTABLISHED PATIENT^2^32
 ;;^UTILITY(U,$J,358.4,303,0)
 ;;=CONSULTS - OUTPT^4^32
 ;;^UTILITY(U,$J,358.4,304,0)
 ;;=EYE CODES^1^32
 ;;^UTILITY(U,$J,358.4,305,0)
 ;;=CONSULTS - INPT^5^32
 ;;^UTILITY(U,$J,358.4,306,0)
 ;;=HOSPITAL CARE - INITIAL^6^32
 ;;^UTILITY(U,$J,358.4,307,0)
 ;;=HOSPITAL CARE - SUBSEQUENT^7^32
 ;;^UTILITY(U,$J,358.4,308,0)
 ;;=HOSPITAL CARE - DISCHARGE^8^32
 ;;^UTILITY(U,$J,358.4,309,0)
 ;;=OBSERVATION CARE - INITIAL^9^32
 ;;^UTILITY(U,$J,358.4,310,0)
 ;;=OBSERVATION CARE - SUBSEQUENT^10^32
 ;;^UTILITY(U,$J,358.4,311,0)
 ;;=OBSERVATION CARE - DISCHARGE^11^32
 ;;^UTILITY(U,$J,358.4,312,0)
 ;;=INPT or OBS - ADMIT & DISCHARGE SAME DAY^12^32
 ;;^UTILITY(U,$J,358.4,313,0)
 ;;=EEF Version 2022 January^13^32
 ;;^UTILITY(U,$J,358.4,314,0)
 ;;=PROC - LID / LACRIMAL^8^33
 ;;^UTILITY(U,$J,358.4,315,0)
 ;;=PROC - LASER / CRYO^11^33
 ;;^UTILITY(U,$J,358.4,316,0)
 ;;=PROC - CORNEA / CONJ^7^33
 ;;^UTILITY(U,$J,358.4,317,0)
 ;;=MEDICATIONS^13^33
 ;;^UTILITY(U,$J,358.4,318,0)
 ;;=PROC - INJECTIONS / ALL^10^33
 ;;^UTILITY(U,$J,358.4,319,0)
 ;;=IMAGE / PHOTOS^3^33
 ;;^UTILITY(U,$J,358.4,320,0)
 ;;=REFRACT / GLASSES / CL^2^33
 ;;^UTILITY(U,$J,358.4,321,0)
 ;;=TEST - CATARACT / CORNEA^5^33
 ;;^UTILITY(U,$J,358.4,322,0)
 ;;=TEST - GLAUCOMA^4^33
 ;;^UTILITY(U,$J,358.4,323,0)
 ;;=TEST - OTHER^6^33
 ;;^UTILITY(U,$J,358.4,324,0)
 ;;=EDUCATION / COUNSELING^14^33
 ;;^UTILITY(U,$J,358.4,325,0)
 ;;=EYE SURGERY CODES^12^33
 ;;^UTILITY(U,$J,358.4,326,0)
 ;;=PROC - INJECTIONS / VEGF^9^33
 ;;^UTILITY(U,$J,358.4,327,0)
 ;;=TEST - ERG / VEP^15^33
 ;;^UTILITY(U,$J,358.4,328,0)
 ;;=DIABETIC EYE EXAM^1^33
 ;;^UTILITY(U,$J,358.4,329,0)
 ;;=LOW VISION / BLINDNESS^21^34
 ;;^UTILITY(U,$J,358.4,330,0)
 ;;=RETINA - VASCULAR^12^34
 ;;^UTILITY(U,$J,358.4,331,0)
 ;;=EYELIDS / LASHES^2^34
 ;;^UTILITY(U,$J,358.4,332,0)
 ;;=NEURO / STRABISMUS^18^34
 ;;^UTILITY(U,$J,358.4,333,0)
 ;;=ORBIT - PLASTICS^20^34
 ;;^UTILITY(U,$J,358.4,334,0)
 ;;=VITREOUS^17^34
 ;;^UTILITY(U,$J,358.4,335,0)
 ;;=ORBIT - TRAUMA^19^34
 ;;^UTILITY(U,$J,358.4,336,0)
 ;;=LACRIMAL / NLD / NEOPLASMS^3^34
 ;;^UTILITY(U,$J,358.4,337,0)
 ;;=MOST FREQUENT^1^34
 ;;^UTILITY(U,$J,358.4,338,0)
 ;;=CONJUNCTIVA / SCLERA^4^34
 ;;^UTILITY(U,$J,358.4,339,0)
 ;;=CORNEA / ULCER^5^34
 ;;^UTILITY(U,$J,358.4,340,0)
 ;;=LENS / CATARACT / POSTOP^6^34
 ;;^UTILITY(U,$J,358.4,341,0)
 ;;=IRIS / UVEITIS^7^34
 ;;^UTILITY(U,$J,358.4,342,0)
 ;;=GLAUCOMA - OPEN ANGLE^8^34
 ;;^UTILITY(U,$J,358.4,343,0)
 ;;=GLAUCOMA - CLOSED ANGLE^9^34
 ;;^UTILITY(U,$J,358.4,344,0)
 ;;=GLAUCOMA - SECONDARY^10^34
 ;;^UTILITY(U,$J,358.4,345,0)
 ;;=RETINA - CHOROID / TUMORS / INFLAM^14^34
 ;;^UTILITY(U,$J,358.4,346,0)
 ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^34
 ;;^UTILITY(U,$J,358.4,347,0)
 ;;=RETINA - MACULA^11^34
 ;;^UTILITY(U,$J,358.4,348,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^34
 ;;^UTILITY(U,$J,358.4,349,0)
 ;;=PMH / OTHER^22^34
 ;;^UTILITY(U,$J,358.4,350,0)
 ;;=RETINA - VEGF INJECT DX CODES^16^34
 ;;^UTILITY(U,$J,358.4,351,0)
 ;;=RETINA - DIABETIC RETINOPATHY^13^34
 ;;^UTILITY(U,$J,358.4,352,0)
 ;;=NEW PATIENT^2^35
 ;;^UTILITY(U,$J,358.4,353,0)
 ;;=ESTABLISHED PATIENT^1^35
